Blood Components and Derivatives part 2 Flashcards
It is the component remaining after cryoprecipitate is prepared
Cryopoor plasma
Vol of Cryopoor plasma
200ml
Shelf Life of Cryopoor Plasma
same as FFP 1 year -18*C or below
Cryopoor Plasma has a minimal concentration of what Clotting factors
Fibrinogen , Factor VIII and VWF
Fxn/Uses of Cryopoor Plasma
Used in patients with hemolytic uremic syndrome , Thrombotic Thrombocytopenic Purpura
Volume of Cryoprecipitate
10-15ml
Shelf life of Cryoprecipitate
1 year @ -18*C below
Shelf life of Cryoprecipitate after thawing
6hrs
Cryoprecipitate used when there is congenital or acquired deficiencies of _______ and Factor ______
Fibrinogen and Factor XIII
Maybe benefecial in bleeding due to uremic platelet dysfunction not responding to desmopressin, estrogen
Cryoprecipitate
Uses of Cryoprecipitate
VWF , Hemophilia A when virus inactivated factor concentrates are not available
Deficiency in Factor 1 and 13
Volume of Factor VIII ( Lyophilized)
25 ml of sterile diluents for reconstitution
Shelf life of Factor V111 ( Lyophilized )
2years @ 2-8*C
Factor IX complex
Factor 2, 7, 9 and other proteins
Used to treat hemophilia B and patients with inhibitors to factor 8 and 9
Plasma derived factor 9
Antithrombin 3 concentrate are prepared from pooled human plasma by __________
Modified cold ethanol fractionation
In Antithrombin 3 concentrate treatment is for prophylaxis of thrombotic events in patient w/ congenital antithrombin deficiency . What are these congenital antithrombin defeciency
DIC , Heparin resistance , Sepsis , Deep Vein thrombosis , Pulmonary Embolism
Antithrombin 3 concentrate volume
Volume per manufacturers direction
What is the purpose of Solvent/Detergent treatment to plasma
To deactivate lipid enveloped viruses ( HIV , HCV)
Vol. of S/D treated plasma
200 ml
Shelf life of S/D treated plasma
1 year @-18 *C
True or False . S/D treated plasma has minimal content of Low Molecular Weight VWF
False S/D treated plasma has minimal content of High Molecular Weight VWF
Plasma as in FFP , stored and released for use after donor has been retested negative for viral markers after days or more , allowing for window period infections to seroconvert
Donor Retested Frozen Plasma
In Donor Restested Frozen Plasma .donor has been retested negative for viral markers after_____ days or more , allowing for window period infections to seroconvert
112 days
Volume of Donor Retested Frozen Plasma
200-260 ml
Difference between Donor Retested Frozen Plasma and FFP
Donor Retested Frozen Plasma has lower risks of viral transmission than FFP
Albumin Shelf life
5 years @ 2-10*C
Volume of Albumin
250-500ml
How many % of albumin and globulin are there in Plasma Protein Fraction
83 % Albumin , 17 % globulin
In Plasma Protein Fraction Hypotension may occur when givent at males over __ml/min
10 ml/min
Plasma Protein Fraction shelf life
3 years below 30*C
Plasma Protein Fraction volume
250-500ml
Albumin contraindications
Dehydrated Patients
Used in Primary humoral immunodeficiency, ITP , Bone marrow transplant and pediatric HIV infection
Immunoglobulin Intravenous
Immunoglobulin Intravenous volume
10-200ml
Shelf life of Immunoglobulin Intravenous
3 years @ 2-8*C
Immunoglobulin Intravenous gained acceptance in the treatment of ______
Guillain Barre’s Syndrome
Immunoglobulin Intravenous antibodies
Mostly IgG , Traces of IgA and IgM
Uses of Rh Ig
Prevents Rh alloimmunization of Rh neg. individual exposed to the D antigen
Used to prevent HDN
IgG anti-Rho full dose is ___µg , minidose is ____µg
300µg and 50µg
Volume of Rh Ig
1ml
Shelf life of Rh Ig
1/2 years @ 2-8*C